Cryo-Save Group NV, a Dutch company that preserves cord-blood stem cells for 20 years or more after the sample is taken at birth, has successfully floated its shares on the Alternative Investment Market (AIM) of the London Stock Exchange.
Cryo-Save Group NV, a Dutch company that preserves cord-blood stem cells for 20 years or more after the sample is taken at birth, has successfully floated its shares on the Alternative Investment Market (AIM) of the London Stock Exchange.